Quietmind Foundation

  • About
  • Services
    • Medical Marijuana
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
    • Cosmetic Study of Wrinkles
  • Research
  • Equipment
  • Blog

Light Therapy for Dementia Clinical Trial

After successfully completing initial safety and feasibility trials, Quietmind Foundation, in cooperation with Texas A&M and Baylor Research Institute, are enrolling adults (50-85) with memory loss for a new innovative clinical study. 
About The Clinical Trial
In cooperation with Texas A&M University's Dept. of Neurosurgery, Quietmind Foundation is enrolling
 individuals age 50-85 years experiencing memory problems and who have been independently diagnosed with early to mid-stage dementia to participate in this trial. The study uses low-level light stimulation directed to the head. The stimulation sessions are conducted at home, twice daily, for 5 minutes over 60 consecutive days. The trial is randomized, placebo controlled and double blind.
Services Cost
All study-related services are provided at no cost and local travel costs are covered. 

Compensation 
After completing three, two-hour assessments all subjects are paid a total of $225. 

What's involved in this trial?
Individuals that match the clinical trial eligibility criteria will go through two unique assessments at the start, mid-point, and ending of the trial period. 
  1. First, subjects will complete a Quantitative EEG assessment. This assessment involves wearing a cap with sensors that record the brain's electrical activity. This is a non-invasive procedure and completed in less than 30-minutes. This assessment is conducted in-person.
  2. Secondly, subjects will complete a standardized memory assessment. This assessment will take an hour and is conducted remotely by the study neuropsychologist.
Following these first two assessments, participants will receive a light therapy device that they will wear for 5-minutes, twice daily for 2 months. This device uses safe LED lights that stimulate blood flow and reduce inflammation in the brain.

Participants re-do the EEG and cognitive assessments twice more during the two month trial.
Picture
Dr. Marvin Berman, PhD CBT is the founder of the Quietmind Foundation and leading the research trial.

    Take The Quick Eligibility Assessment Below 
    Please complete all sections and we will contact you to answer any additional questions. If you qualify, we will provide you with the informed consent forms for your review and arrange an intake appointment to begin the study.


Submit Answers

Our mission is to study, provide and promote drug-free, low-cost, noninvasive approaches to understanding and treating disorders that affect people's thinking, behavior, and movement.


Office Hours

Monday & Thursday: 11am - 6pm
In-office and
​remote conferencing available

Locations

Main Office- PA
​8120 Old York Road, Suite 140
Elkins Park, PA 19027

New York Office
1619 3rd Ave. Suite 202 New York, NY 10128
​
(clinical trial evaluation only)

Telephone Number

610-940-0488

Fax Number

215-359-0630

Email

info@quietmindfdn.org

Support Us

QuietMIND Foundation is a 501c3 charitable nonprofit. Donations are fully tax deductible. We work to provide services regardless of ability to pay, please help those who need help.
© 2020 Quietmind Foundation | All Rights Reserved | Quietmind Foundation is a not-for-profit 501(c)(3) organization.
  • About
  • Services
    • Medical Marijuana
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
    • Cosmetic Study of Wrinkles
  • Research
  • Equipment
  • Blog